The Terrapinn Advanced Therapies meeting is an international event for developers, investors and regulatory officials involved in the discovery, development and commercialisation of cell and gene therapies. This year, the speakers will feature Peter Marks, director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration.
